U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241221) titled 'Antenatal Myo-inositol Supplementation in Pre-existing Diabetes' on Sept. 18.
Brief Summary: This feasibility pilot study aims to gather data that can guide the design of a larger, more comprehensive trial to establish the effects of myo-inositol supplementation on supporting healthy outcomes in pregnancies complicated by Type 2 Diabetes Mellitus (T2DM). It seeks to assess myo-inositol's potential to support fetal and neonatal health, and optimise maternity outcomes as a complementary approach and adjuvant to existing diabetes mellitus therapies, as well as investigate the underlying biological mechanisms.
Study Start Date: Nov., 2...